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C BY-NC-Abstract Hundred and twenty microbial isolates could be isolated from different soil samples col-
lected from different localities in Egypt. One of the bacterial cultures AZ-SH-B8 was found to pro-
duce a wide spectrum antimicrobial agent when cultivated on plastic wastes. The bacterial culture
AZ-SH-B8 could be isolated from a soil sample collected from Sharkia governorate, Egypt. From
the taxonomic features, the bacterial isolate AZ-SH-B8 matches with Pseudomonas aeurginosa in
the morphological, physiological and biochemical characters and conﬁrmation by using API20E
system. Thus, it was given the suggested name P. aeurginosa, AZ-SH-B8. The parameters control-
ling the biosynthetic process of antimicrobial agent formation includes: innoculum size, different
pH values, different temperatures, different incubation period, different carbon and nitrogen
sources and different mineral salts concentrations (KNO3, K2HPO4, MgSO4Æ7H2O and KCl) were
fully investigated. The active metabolite was extracted using n-butanol (1:1, v/v) at pH 7.0. The sep-
aration of the active ingredient and its puriﬁcation was performed using both thin layer chromatog-
raphy (TLC) and column chromatography (CC) techniques. The physico-chemical characteristics of
the puriﬁed antibiotic viz. color, melting point, solubility, elemental analysis, spectroscopic charac-
teristics and chemical reactions have been investigated. This analysis indicates a suggested empirical
formula of C13H21N3O6S2. The minimum inhibition concentrations ‘‘MICs’’ of the puriﬁed antimi-om (H.M. Atta).
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Sparsomycin antibiotic produced by P. aeurginosa, AZ-SH-B8.
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The antibiotic Sparsomycin is a universal translation inhibitor
that blocks protein synthesis in all species (Ottenheijm et al.,
1986). The broad spectrum of Sparsomycin action indicated
that the drug was targeted to a highly conserved component
of the translation machinery. The relevance of the target was
also supported by the fact that mutations inducing high
resistance to Sparsomycin have not been reported, and only
a moderately resistant strain has been found in Halobacterium
salinarium (La´zaro et al., 1996).
In fact, it was soon shown that Sparsomycin blocks the pep-
tide bond formation (Jayaraman and Goldberg, 1968). The
drug binds and causes important conformational changes in
the peptidyl transferase active center. Thus, it was found that
Sparsomycin can block the binding of substrates at the A-site
(Ravel et al., 1970) but enhances binding to the P-site (Jimenez
et al., 1970). Actually, Sparsomycin has been a very powerful
tool in the study of the structure and function of the ribosome
(Gale et al., 1981). Recently, the antibiotic was found to inter-
act with nucleotide A2602 in the peptidyl transferase center of
the bacterial ribosome (Porse et al., 1999).
The drug was initially developed as a potential antitumor
agent, although toxicity soon limited its clinical application
(McFarlane et al., 1966). Nevertheless, the synthesis of a series
of Sparsomycin derivatives with higher inhibitory activities
(van den Broek et al., 1987) has led to a reappraisal of its poten-
tial as an anticancer drug (Fiebig et al., 1990; Hofs et al., 1994).
Sparsomyin is produced by Streptomyces sparsogenes,
which is obviously resistant to the drug. Organisms producing
toxic compounds, including antibiotics, use different ap-
proaches to defend themselves from their own action (Burdett,
1996). Not the least frequent approach is to modify the target,
making it insensitive to the drug. Thus, methylation of speciﬁc
residues within the 16S rRNA makes the ribosomes of many
aminoglycoside antibiotic producers resistant to their respec-
tive products (Skeggs et al., 1985; Thompson et al., 1985).
The same strategy is used by the producers of macrolides
(Lai et al., 1973), lincosamides (Skinner et al., 1983), pactamy-
cin (Ballesta and Cundliffe, 1991), and thiostrepton (Cundliffe
and Thompson, 1979). The study of these resistance mecha-
nisms has provided relevant information on the antibiotic
mode of action and on the ribosomal binding site at the molec-
ular level. It would be important, therefore, to see whether S.
sparsogenes, like other antibiotic-producing streptomycetes,
has managed to modify the highly conserved Sparsomycin tar-
get site to make the ribosomes resistant to the drug. Alterna-
tively, as in the case of other producers, a different resistance
mechanism, such as drug inactivation or permeability barrier
alterations, might have evolved (Cundliffe, 1989), perhaps be-
cause modiﬁcation of the target is not possible without seri-
ously affecting its activity.
We have approached the study of Sparsomycin resistance by
directly analyzing the producer and by trying to characterize
genetic determinants from S. sparsogenes that provide resis-tance in Streptomyces lividans, an organism susceptible to the
drug.
In the present work we describe the isolation of a Bacterial
strain from Egyptian soil, which generates an antimicrobial
agent(s). The identiﬁcation of this strain is based on the cul-
tural, morphology, physiology and biochemical characteristics.
The bioactive substance was isolated, puriﬁed, and spectro-
scopic analysis and biological activities were determined.
2. Materials and methods
2.1. Microorganism
The bacterial AZ-SH-B8 was isolated from soil sample col-
lected from Sharkia governorate. It was puriﬁed using the soil
dilution plate technique described by Williams and Davies
(1965).
2.2. Identiﬁcation of Bacterial isolate, AZ-SH-B8
2.2.1. Morphological characteristics
Morphological characteristics of colonies like color, Gram
reaction, cell shape, spore formation, motility and diffusible
pigment were investigated.
2.2.2. Physiological and biochemical characteristics
Lipase (Elwan et al., 1977); protease (Ammar et al., 1991); pec-
tinase (Ammar et al., 1995a); a-amylase (Ammar et al., 1998);
Lecithinase was conducted on egg-yolk medium according to
the method of Nitsh and Kutzner (1969) and catalase test
(Jones, 1949). Aesculin broth has been done according to
Gordon et al. (1974). Nitrate reduction was performed accord-
ing to the methods of Gordon (1966). Hydrogen sulﬁde; poly-
hydroxyl butyrate accumulation, King A&B, Methyl red,
Voges–Proskauer, indol production, urea test, gelatein lique-
faction, Levan formation, arginine dihydrolase, malonate uti-
lization, phenyl alanine deamination, utilization of KCN and
oxidase test were carried out according to Cowan (1974).
The utilization of different carbon and nitrogen sources was
carried out according to Shirling and Gottlieb (1966).
2.3. Factors effecting on the biosynthesis of the antimicrobial
agent
These included inoculum size, incubation period, pH values,
incubation temperatures; different carbon and nitrogen
sources, starch, potassium nitrate, K2HPO4, MgSO4Æ7H2O
and KCl have been determined by the standard methods.
2.4. Fermentation and puriﬁcation of AZ-SH-B8 antibiotic
2.4.1. Fermentation
Pseudomonas aeruginosa AZ-SH-B8 was inoculated into Bax-
ter bottle containing 5 g dry weight of plastics supplied with
Plate 1 A photograph of bacterial isolate AZ-SH-B8 growing
on nutrient agar medium showing Gram negative, short rods
(·1000).
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ents (g/l): NaNO3, 2.0; K2HPO4, 1.1; MgSO4Æ7H2O, 0.5 KCl,
0.5 and peptone 2.0. The pH was adjusted at 6.8 before steril-
ization. Inoculating three discs from bacterial growthTable 1 The morphological, physiological and biochemical propert
Characteristic Result C
Morphological characteristic U
– Color of colonies Yellow L
– Gram reaction Negative D
– Motility + D
– Cell shape Rods D
– Spore former Non-spore former D
D
Diﬀusible pigment Blue–green D
Physiological characteristics
(A) Hydrolysis of
Protein +
Starch 
Lipid +
Egg-yolk (lecithinase) 
Oxidase test +
Catalase test +
(B) Pigment production U
Pyocyanin pigment + L
Carotenoid pigmt + L
Fluorescent pigment + L
Biochemical characteristics L
– Degradation of Esculine + L
– Gelatin liquefaction + L
– H2S production + L
– Nitrate reduction + L
– Urea test  L
– Indole production  G
– Levan formation from sucrose 
– Arginine dihydrolase + 1
– Poly b-hydroxy butyrate accumulation  3
– Utilization of KCN + 5
7
– Phenyl alanine deamination + G
– Voges–Proskauer test  2
– Methyl red test  4
+= positive and = negative.(0.52 · 1013 CFU/disc), after 28 days of incubation at 35 C ﬁl-
tration was carried out through Whatman No. 1 and was fol-
lowed by centrifugation at 5000 rpm for 15 min. The clear
ﬁltrates were tested against the test organism.
2.4.2. Extraction
The clear ﬁltrate was adjusted at pH values and extraction pro-
cess was carried out using different solvents to be added to the
fermentation broth at the level of 1:1 (v/v), respectively. The
organic phase was concentrated to dryness under vacuum by
using a rotary evaporator.
2.4.3. Precipitation
The precipitation process of the antibiotic was carried out
using petroleum ether. The compound precipitate was centri-
fuged at 5000 rpm for 15 min. The antibiotic powder was
tested for its antibacterial activity by using cup assay
method.
2.4.4. Separation
Separation of the antibiotic into its individual components has
been tried by thin layer chromatography using a solvent sys-
tem composed of chloroform and methanol (24:1, v/v).ies of the bacterial isolate AZ-SH-B8.
haracteristic Result
tilization of carbon sources
-Arabinose 
-Xylose 
-Ribose +
-Mannose 
-Glucose +
-Fructose +
-Galactose 
– Mannitol +
– meso-Inositol 
– Sucrose 
– Maltose 
– Lactose 
– Raﬃnose 
– Trehalose 
– Starch 
tilization of nitrogen source
-Glycine 
-Alanine 
-Serine +
-Leucine +
-Valine 
-Lysine +
-Proline +
-Tyrosine +
-Arginine +
rowth in presence of diﬀerent NaCl concentrations (%)
+
+
+

rowth at diﬀerent temperature (C)
0–43 +
5 
Table 2 Identiﬁcation of bacterial isolate AZ-H-B8 by
API20E system.
Test Result
NO3 = nitrate reduction +
TRP= indole production 
GLU= acidiﬁcation 
ADH= arginine dihydrolase +
URE= urease 
ESC= esculin hydrolysis 
GEL= gelatin hydrolysis +
PNPG= p-nitrophenyl-b-D-galactopyranoside
(b-galactosidase)

[GLU] = glucose assimilation +
[ARA] = arabinose assimilation 
[MEN] = mannose assimilation 
[MAN] = mannitol assimilation +
[NAG] = N-acetylglucosamine assimilation +
[MAL] = maltose assimilation 
[GNT] = gluconate assimilation +
[CAP] = caprate assimilation +
[ADI] = adipate assimilation +
[MLT] = malate assimilation +
[CIT] = citrate assimilation +
[PAC] = phenyl-acetate assimilation 
(+) = positive result and () = negative result.
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The puriﬁcation of the antibiotic was carried out by using sil-
ica gel column chromatography. A column of 2.5 · 50 cm was
used for this purpose. Chloroform and methanol 10:1 (v/v),
was used as an eluting solvent. The column was left for over
night until the silica gel (BDH – 60–120 mesh) was completely
settled. One milliliter crude extract to be fractionated was
added on the silica column surface and the extract was ad-
sorbed on top of silica gel. Fifty fractions were collected (each
of 5 ml). Antibiotic activities were performed for each separate
fraction.
3. Physico-chemical properties of AZ-SH-B8 antibiotic
3.1. Elemental analysis
The elemental analysis C, H, O, N, and S was carried out by
the microanalytical center of Cairo University, Egypt.
3.2. Spectroscopic analysis
The IR, UV, mass spectrum and HPLC were determined at the
micro analytical center of Cairo University, Egypt.
3.3. Reaction of the antibiotic with certain chemical test
For this purpose the following reactions were carried out: Mol-
ish’s reaction, Fehling reaction, Sakaguchi reaction, Ninhydrin
reaction, Ehrlish reaction, nitroprusside reaction, ferric chlo-
ride reaction, and Mayer reaction.
3.4. Biological activity
The minimum inhibitory concentration (MIC) has been deter-
mined by cup method assay (Kavanagh, 1972; National
Committee for Clinical Laboratory Standards, 2003).
3.5. Characterization of the puriﬁed antibiotic
The antibiotic produced by P. aeruginosa, AZ-SH-B8 was tried
to be identiﬁed according to the recommended international
references of (Umezawa, 1967, 1977; Berdy, 1974, 1980a–c)
and British pharmacopoeia 2000.
4. Results
4.1. Characterization of the bacterial isolate, AZ-SH-B8
Identiﬁcation of these strains to the species aswell as their speciﬁc
characteristics will be given here after for each individual strain.
This isolate (Plate 1 and Table 1) was isolated from El-
Sharkia governorate, thus symbolized AZ-SH-B8. Color of
colonies is yellow, Gram negative, motile, short rods, non-
spore former, aerobic. It produces blue green water soluble
pigment, hydrolyses protein, and lipid, oxidase and catalase
(+), but do not hydrolyse starch and lecithin. The ﬂuorescent,
pyocyanin and carotenoid pigments can be produced. Degra-
dation of esculine is positive; production of H2S, gelatine
liquefaction, KCN, nitrate reduction, arginine dihydrolaseand phenyl alanine deamination are positive, whereas utiliza-
tion of urea, levan formation from sucrose, production of in-
dole, methyl red and Voges–Proskauer, and poly b-hydroxy
butyrate accumulation are negative.
It utilizes, D-ribose, D-glucose, D-fructose and mannitol and
no growth on L-arabinose, D-xylose, D-mannose, D-galactose,
meso-inositol, lactose, rafﬁnose, sucrose, maltose, trehalose
and starch was detected. Good growth was detected on
L-serine, L-leucine, L-lysine, L-proline, L-tyrosine, and L-argi-
nine. No growth on glycine, L-alanine and L-valine was de-
tected. Good growth in the presence of NaCl up to 5% was
detected. Good growth was detected within temperature range
from 20 to 43 C.
4.2. Identiﬁcation of bacterial isolate,AZ-SH-B8byAPI20Esystem
The most potent bacterial isolate, viz. AZ-SH-B8, gives positive
results with nitrate reduction, arginine dihydrolase, gelatin
hydrolysis, glucose assimilation and assimilation of mannitol,
N-acetylglucosamine, gluconate, caprate, adipate, malate and
citrate (Table 2).
4.3. Identiﬁcation of the bacterial isolate, AZ-SH-B8
This was performed basically according to the recommended
international Key’s viz. (Buchanan and Gibson, 1974; Krieg,
1984; Hensyl, 1994). On the basis of the previously collected
data and in view of the comparative study of the recorded
properties of bacterial isolate, AZ-SH-B8 Table 1 in relation
to reference strain, viz. P. aeruginosa, and conﬁrmed by
API20E strip system (Table 2) it could be stated that bacterial
isolate, AZ-SH-B8 is suggestive of being related to P. aerugin-
osa, AZ-SH-B8 (Table 3).
Table 3 A comparative study of the characteristics of the
bacterial isolate, AZ –SH-B8 in relation to Reference strain, P.
aeruginosa.
Characteristics AZ-SH-B8 Pseudomonas
aeruginosa
Morphological characteristic
Gram reaction Negative Negative
Cell form Rod shape Rod shape
Motility Motile Motile
Physiological and biochemical characteristic
Diﬀusible pigment production Blue-green Blue-green
Hydrolysis of
Protein + +
Starch  
Lipid + +
Lecithin (egg-yolk) + +
Levan formation + +
Arginine dihydrolase  
Oxidase reaction + +
Catalase test + +
Phenyl alanine deamination + +
Poly-b-hydroxybutyrate accumulation + +
Growth at 41 C + +
Utilization of carbon sources
L-Arabinose  
D-Xylose  
D-Ribose + +
D-Mannose  
D-Glucose + +
D-Fructose + +
D-Galactose  
Mannitol + +
meso-Inositol  
Sucrose  
Trehalose  
Utilization of nitrogen sources
L-Glycine  d
L-Alanine  +
L-Leucine + +
L-Valine  d
L-Lysine + +
L-Proline + +
L-Arginine + +
L-Tyrosine + +
+= positive, = negative, d = doubtful.
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The antimicrobial agent produced by the bacterial isolate
exhibited various degrees of activities against Gram positive
and Gram negative bacteria and fungi (unicellular and ﬁlamen-
tous fungi) (Table 4).
4.5. Factors effecting on the biosynthesis of the antimicrobial
agent
Maximum antimicrobial activity biosynthesis could be re-
corded with different inoculum sizes for three discs; incubation
period for 28 days; pH 6.0, temperature 35 C; glucose best
carbon source; peptone best nitrogen source as well as, the bestconcentration of K2HPO4, MgSO4Æ7H2O and KCl is 1.1 g/l;
0.5 g/l and 0.5 g/l, respectively.
4.6. Fermentation, separation, precipitation and puriﬁcation
antimicrobial agent(s)
The fermentation process was carried out for 28 days at 35 C.
Filtration has been determined through Whatman No. 1 and
followed by centrifugation at 5000 rpm for 15 min.
Only clear ﬁltrates (supernatant) were tested for their
antimicrobial activity. The clear ﬁltrate (15 l) was adjusted
at pH 7.0 then the extraction process was carried out.
Butanol was added to the fermentation broth at the level
of 1:1 (v/v). The organic phase was collected, evaporated
under reduced pressure using a rotary evaporator. The
residual syrup was dissolved in least amount of DMSO
and ﬁltered. The ﬁltrates were tested for their antimicrobial
activity.
Only one fraction was obtained with petroleum ether (b.p.
40–60 C) by centrifugation at 5000 rpm for 15 min. Crude
deep green was tested for their antimicrobial activities by using
cup diffusion method.
Separation of the antibiotic into individual components has
been carried out by thin layer chromatography (TLC).
The obtained results revealed that one band at Rf 0.7 exhib-
ited obvious inhibitory effects against the growth of both
Gram positive and Gram negative bacteria and fungi (unicellu-
lar and ﬁlamentous fungi).
The puriﬁcation of the antibiotic was carried out by using
silica gel column chromatography. The active fractions were
concentrated. The maximum activity was recorded at fraction
No. 28. A summary of the ampliﬁed scheme for the extraction
was recorded and puriﬁcation of the antibiotic was biosynthe-
sized by P. aeruginosa, AZ-SH-B8.
4.7. Physicochemical characteristics of the puriﬁed antibiotic
The physical characteristics such as melting point 360 C and
soluble in water, chloroform, n-butanol, methanol, ethanol,
DMSO, carbon tetra chloride, but insoluble in petroleum
ether, hexane and benzene were investigated.
4.7.1. Elemental analysis
A study of the elemental analysis of the antibiotic showed the
following C = 41.13; H = 5.58; N = 11.07, O = 25.30 and
S = 16.90: leads to an emperical formula of: C13H21N3O6S2.
4.7.2. Spectroscopic characteristics
The spectroscopic characteristics of the antibiotic revealed the
presence of the maximum absorption peak in infra-red absorp-
tion spectrum represented by 19 peaks (Fig. 1); UV at 270 and
300 nm (Fig. 2). Mass-spectrum showed that the molecular
weight is 379 (Fig. 3) and NMR-spectrum was also determined
(Fig. 4).
4.7.3. Biochemical reaction of antibiotic
The reactions revealed the detection of certain groups in the
molecule investigated. The antibiotic showed positive results
with nitroprusside, ferric chloride and Mayer reactions (Table
5).
Figure 1 IR spectrum of antimicrobial agent produced by Pseudomonas aeurginosa, AZ-SH-B8.
Table 4 Antimicrobial potentialities of the active microbial isolates isolated from various localities under solid state by fermentation
using (plastic).
Organism
number
Mean values of inhibition zone (in mm) against
Bacteria Fungi
G +ve Cocci G +ve Bacilli G ve strain Unicellular Multicellular
Micrococcus
lutues,
ATCC 9341
Staph.
aureus,
NCTC 7447
B.subtilis,
NCTC
10400
B.pumilus,
NCTC
8214
E. coli,
NCTC
10416
Klebsiella
pneumonia,
NCIMB 9111
P. aeurginosa,
ATCC 10145
Candida
albicans,
IMRU 3669
Asp.
ﬂavus
Penicillum
chresogenum
AZ-SH-B8 27.0 26.0 27.5 27.0 26.0 26.0 24.0 22.0 21.0 20.0
Figure 2 Ultraviolet absorbance of antimicrobial agent produced by Pseudomonas aeurginosa, AZ-SH-B8.
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On the basis of the recommended keys (Umezawa, 1977;
Berdy, 1974, 1980a–c; British pharmacopoeia, 2000) for
the identiﬁcation of antibiotics produced by P. aeruginosa,
AZ-SH-B8 and in view of the comparative study of the
recorded properties of the antibiotics, it could be stated thatthe antibiotic is suggestive of belonging to Sparsomycin antibi-
otic (Table 6).
4.7.5. Biological activities of the puriﬁed antibiotic
Data of the antimicrobial spectrum of antibiotic indicated that
the antibiotic is fairly active against both Gram positive and
Table 5 Summarizes the response of the antimicrobial agent
produced by Pseudomonas aeurginosa, AZ-SH-B8 to certain
biochemical reactions.
Chemical test Result Remark
Molish’s reaction  Absence of sugar moiety
Fehling test  Absence of free aldehyde
or keto sugar
Ninhydrin test  Absence of free-NH2 group
Sakaguchi reaction  Arginin is Absent
Nitroprusside reaction + Presence of Sulfur
Ferric chloride reaction + Presence of di-ketons group
Ehrlish reaction  Absence of indolic acid
Mayer reaction + Presence of nitro group
Figure 3 Mass spectrum of antimicrobial agent produced by Pseudomonas aeurginosa, AZ-SH-B8.
Figure 4 NMR spectrum of antimicrobial agent produced by Pseudomonas aeurginosa, AZ-SH-B8.
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(Table 7).
5. Discussion
The P. aeruginosa, AZ-SH-B8 was isolated from Sharkia gov-
ernorate. The isolate was found to produce a wide spectrum
antimicrobial agent against Gram-positive and Gram-negative
bacteria and was slightly active against unicellular and ﬁlamen-
tous fungi when cultivated on plastic wastes (Ammar et al.,
2001; Scheller and Conrad, 2005).Identiﬁcation process has been carried out according to the
Key’s giving in Bergey’s Manual of Determinative Bacteriol-
ogy, 8th edition (Buchanan and Gibbson, 1974), Bergey’s
Manual of Determinative Bacteriology, vol. I (Krieg, 1984)
and Bergey’s Manual of Determinative Bacteriology, 9th edi-
tion (Hensyl, 1994). The morphological characteristics and
microscopic examination of the isolate were compared with
the identiﬁed bacteria. As the isolate Gram negative reaction,
rod shape, motile, aerobic, oxidase test is positive it was iden-
tiﬁed as Pseudomonas (Hensyl, 1994).
In view of the recorded data, the identiﬁcation of bacterial
isolate AZ-SH-B8 was suggestive of being belonging to P.
aeruginosa, AZ-SH-B8.
In view of all the previously recorded data, the identiﬁca-
tion of bacterial isolate AZ-SH-B8 was suggestive of being
belonging to P. aeruginosa, AZ-SH-B8, a bacterial with a wide
spectrum antibiotic productivity (Radwan, 2008).
Maximum antimicrobial activity biosynthesis could be re-
corded withdifferent inoculum sizes for three discs; incubation
period for 28 days (Adinarayana et al., 2002); pH 6.0
(El-Henawy, 2006); temperature 35 C (Kunnari et al., 1997;
Atta, 1999); glucose best carbon source (Yasutaka et al.,
2004); peptone best nitrogen source (Hosokawa et al., 2001)
as well as, the best concentration of K2HPO4, MgSO4Æ7H2O
and KCl is 1.1 g/l; 0.5 g/l and 0.5 g/l, respectively (Khalifa,
2008; Radwan, 2008).
The active metabolites were extracted by n-butanol at pH
7.0 (Atta et al., 2009a,b; Atta, 2010).
Table 6 A comparative study of the characteristic properties of the antimicrobial agent produced by P. aeurginosa, AZ-SH-B8 in
relation to reference antibiotic (Sparsomycin).
Characteristic Puriﬁed antimicrobial agent Sparsomycin
(1) Melting point 360 C 361 C
(2) Molecular weight 379 379.45
(3) Chemical analysis
C 41.13 41.13
H 5.58 5.58
N 11.07 11.07
O 23.30 23.30
S 16.90 16.90
Ultra violet 270 and 300 270 and 302
Formula C13H21N3O6S2 C13H21N3O6S2
Active against Active against Gram positive and
Gram negative bacteria and
unicellular and ﬁlamentous fungi
Active against Gram positive
and Gram negative bacteria
and unicellular and ﬁlamentous fungi
ND= no data and = negative results.
Table 7 The antimicrobial spectrum of the antibiotic by using
paper disc diffusion method (Kavanagh, 1972).
Test organisms MIC (lg/ml) concentration
of antibiotic produced
by P. aeurginosa, AZ-SH-B8
(A) Bacteria
(a) Gram positive cocci
Staph. aureus, NCTC 7447 3.9
Micrococcus luteus, ATCC 9341 2.6
(b) Gram positive bacilli
Bacillus subtilis, NCTC 10400 2.6
(c) Gram negative bacteria
Escherichia coli, NCTC 10416 5.85
Klebsiella pneumonia, NCIMB 9111 7.8
(B) Fungi
(a) Unicellular fungi
Candida albican, IMRU 3669 31.25
(b) Filamentous fungi
Asp. ﬂavus, IMI 111023 46.87
Penicillium chrysogenium 62.5
42 H.M. Atta, H.G. RadwanSeparation of antibiotic into individual components has
been tried by thin-layer chromatography using a solvent sys-
tem composed of chloroform and methanol (24:1, v/v) as the
developing solvent (Zhang et al., 2007; Atta et al., 2009a,b).
The band with an Rf value at 0.7 which indicated the presence
of one compound. For the purpose of puriﬁcation process, the
antibiotic was allowed to pass through a column chromatogra-
phy packed with silica gel and the eluting solvent was com-
posed of chloroform and methanol (9:1, v/v), 50 fractions
were collected and tested for their activities. The maximum
activity was recorded at fraction No. 28. Similarly, many
workers used a column chromatography packed with silica
gel and an eluting solvent composed of various ratios of chlo-
roform and methanol similarly (Howells et al., 2002; Kharel
et al., 2004; Radwan, 2008).
The physico-chemical characteristics of the puriﬁed antibi-
otic revealed that, melting point is 360 C, soluble in water,chloroform, n-butanol, methanol, ethanol, DMSO, carbon tet-
ra chloride, but insoluble in petroleum ether, hexane and ben-
zene. Similar results were recorded by (Lotﬁ et al., 2003; El-
Tayeb et al., 2004; Atta, 2010).
A study of the elemental analysis of the antibiotic showed
the following C = 41.13; H = 5.58; N = 11.07, O = 25.30
and S = 16.90: lead to an imperical formula of:
C13H21N3O6S2.
The spectroscopic characteristics of the antibiotic revealed
the presence of the maximum absorption peak in UV at 270
and 300 nm, infra-red absorption spectrum represented by 19
peaks. Mass-spectrum showed that the molecular weight is
379 and NMR-spectrum was also determined. The biochemi-
cal tests of the antibiotic gave positive reaction with Nitroprus-
side, Ferric chloride and Mayer reactions (Table 7). Similar
studies were conducted by (Bastian et al., 2001; Arya, 2005;
Imnagaki et al., 2006; Sekiguchi et al., 2007; Radwan, 2008).
The MIC of the antibiotic under study exhibited to be fairly
active against both Gram positive and Gram negative bacteria
and unicellular and ﬁlamentous fungi. Similar investigations
and results were attained by Matsuoka and Saski (2004),
Imnagaki et al. (2006) and Sekiguchi et al. (2007).
Identiﬁcation of the antibiotic according to recommended
international keys indicated that the antibiotic is suggestive
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